The favorable prognostic effect of Tregs in CRC has been implied in several studies [20, 29], while others have reported that Tregs promote CRC progression by suppressing the CD4+T-cell response to tumor-associated antigens [30]. This evidence concerns the gene CD4 and colorectal carcinoma.